Capital Fund Management (CFM)’s ChemoCentryx, Inc. CCXI Stock Holding History

Capital Fund Management (CFM)’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-113,844	Closed	-$2.82M	–	1721
2022 Q2	$2.82M	Buy	+113,844	New	+$2.51M	0.03%	706
2021 Q3	–	Sell	-39,101	Closed	-$609K	–	1857
2021 Q2	$524K	Buy	+39,101	New	+$963K	﹤0.01%	1296

Other funds holding CCXI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Capital Fund Management (CFM)'s CCXI Position: Q3 2022 in Review

Capital Fund Management (CFM) sold out of ChemoCentryx, Inc. (CCXI) in Q3 2022, closing a stake of 113,844 shares — an estimated $2.82M sold.

Capital Fund Management (CFM) first reported a position in CCXI in Q2 2021 and held it in 2 quarters. The position peaked at $2.82M in Q2 2022. 217 funds tracked by Wall St. Rank hold CCXI as of Q3 2022.

Capital Fund Management (CFM) reported no remaining ChemoCentryx, Inc. position as of Q3 2022 after selling out during the quarter.
Capital Fund Management (CFM) sold 113,844 ChemoCentryx, Inc. shares in Q3 2022, an estimated $2.82M.
Capital Fund Management (CFM) first reported a position in ChemoCentryx, Inc. in Q2 2021 and held it in 2 quarters.
Capital Fund Management (CFM)'s ChemoCentryx, Inc. position peaked at $2.82M in Q2 2022.
217 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2022.

Based on Capital Fund Management (CFM)'s 13F filing for Q3 2022, filed 14 Nov 2022.